We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMN
601
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.28M | 0.02% |
205,897
+10,900
| +6% | +$72.8K |
|
602
Ooma
OOMA
$550M
| $1.27M | 0.02% |
121,192
-5,800
| -5% | -$73.6K |
|
603
Labcorp
LH
$24.3B
| $1.27M | 0.02% |
+8,544
| New | +$1.19M |
|
604
Park National Corp
PRK
$3.41B
| $1.26M | 0.02% |
12,642
+2,485
| +24% | +$241K |
|
|
CTO
605
CTO Realty Growth
CTO
$743M
| $1.25M | 0.02% |
77,382
+49,531
| +178% | +$811K |
|
|
RVI
606
DELISTED
Retail Value Inc. Common Shares
RVI
| $1.25M | 0.02% |
392,482
+279,790
| +248% | +$859K |
|
607
Ambarella
AMBA
$2.99B
| $1.25M | 0.02% |
28,270
+20,920
| +285% | +$937K |
|
608
Darden Restaurants
DRI
$22.5B
| $1.25M | 0.02% |
10,240
+2,530
| +33% | +$301K |
|
609
Crown Castle
CCI
$32.7B
| $1.25M | 0.02% |
9,550
+1,910
| +25% | +$246K |
|
|
DATA
610
DELISTED
Tableau Software, Inc.
DATA
| $1.23M | 0.02% |
7,410
-243,570
| -97% | -$32M |
|
611
RenaissanceRe
RNR
$13.7B
| $1.22M | 0.02% |
+6,870
| New | +$1.13M |
|
612
Titan International
TWI
$516M
| $1.22M | 0.02% |
248,722
-14,300
| -5% | -$77.8K |
|
|
TLRA
613
DELISTED
Telaria, Inc.
TLRA
| $1.22M | 0.02% |
161,538
-102,716
| -39% | -$768K |
|
614
MarketAxess Holdings
MKTX
$4.15B
| $1.2M | 0.02% |
+3,732
| New | +$1.08M |
|
|
TAST
615
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.2M | 0.02% |
132,695
-78,088
| -37% | -$717K |
|
616
Marchex
MCHX
$79.7M
| $1.19M | 0.02% |
253,873
+107,216
| +73% | +$513K |
|
617
Liberty Global Class A
LBTYA
$3.31B
| $1.17M | 0.02% |
43,347
+8,300
| +24% | +$219K |
|
618
Sierra Bancorp
BSRR
$548M
| $1.17M | 0.02% |
43,031
-391
| -0.9% | -$10K |
|
619
Texas Instruments
TXN
$255B
| $1.17M | 0.02% |
+10,150
| New | +$1.14M |
|
620
Synopsys
SNPS
$71.5B
| $1.16M | 0.02% |
9,040
-70
| -0.8% | -$8.42K |
|
621
Comtech Telecommunications
CMTL
$51.8M
| $1.15M | 0.02% |
40,805
+8,000
| +24% | +$193K |
|
|
CSLT
622
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.15M | 0.02% |
+354,541
| New | +$1.22M |
|
623
MSC Industrial Direct
MSM
$7.02B
| $1.11M | 0.02% |
14,920
-20,260
| -58% | -$1.56M |
|
|
MZTI
624
The Marzetti Company
MZTI
$2.94B
| $1.1M | 0.02% |
7,430
+3,770
| +103% | +$565K |
|
625
Aflac
AFL
$63.9B
| $1.1M | 0.02% |
+20,120
| New | +$1.04M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.